Viewing Study NCT02942095

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:33 PM
Ignite Modification Date: 2026-01-25 @ 8:31 AM
Study NCT ID: NCT02942095
Status: COMPLETED
Last Update Posted: 2023-04-18
First Post: 2016-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Ixazomib and Erlotinib in Solid Tumors
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced Solid Tumors View
None Metastatic cancer View
None Ixazomib View
None MLN9708 View
None Erlotinib View
None Erlotinib hydrochloride View
None OSI-774 View
None CP358774 View
None Tarceva View